Total Holdings
84
Portfolio diversification across 84 positions
IBRN
(NYSEARCA)iShares Neuroscience and Healthcare ETF
$36.89-- (--)
Loading... - Market loading
IBRN ETF Holdings: iShares Neuroscience and Healthcare ETF
Complete portfolio holdings with allocation weights, sector breakdown, and geographic exposure for this Equity ETF. Analyze fund diversification and concentration.
Assets Under Management
$5.20M
Total fund assets
Expense Ratio
0.47%
Annual management fee
Fund Issuer
BlackRock
NYSEARCA
Portfolio Allocations
Distribution breakdown by sector, asset type, and geographic region. Understand the fund's diversification strategy across markets and asset classes.
Loading chart...
Top 50 Holdings by Portfolio Weight
View ticker symbols, company names, asset types, and allocation percentages for each position
Scroll to see more
| # | Symbol | Name | Type | Weight |
|---|---|---|---|---|
| 1 |  | Alkermes plc | Stock | 5.59% |
| 2 |  | Axsome Therapeutics, Inc | Stock | 5.57% |
| 3 |  | Arrowhead Pharmaceuticals, Inc. | Stock | 4.56% |
| 4 |  | Neurocrine Biosciences, Inc | Stock | 4.54% |
| 5 |  | argenx NV ADR | Stock | 4.46% |
| 6 |  | Xenon Pharmaceuticals Inc | Stock | 4.45% |
| 7 |  | PTC Therapeutics, Inc | Stock | 4.23% |
| 8 |  | Centessa Pharmaceuticals PLC ADR | Stock | 3.98% |
| 9 |  | Biogen Inc | Stock | 3.87% |
| 10 |  | Catalyst Pharmaceuticals Inc | Stock | 3.66% |
| 11 |  | Scholar Rock Holding Corporation | Stock | 3.58% |
| 12 |  | ACADIA Pharmaceuticals Inc | Stock | 3.44% |
| 13 |  | Denali Therapeutics Inc. | Stock | 3.30% |
| 14 |  | Dianthus Therapeutics, Inc. | Stock | 3.04% |
| 15 |  | Praxis Precision Medicines, Inc. | Stock | 2.95% |
| 16 |  | Edgewise Therapeutics, Inc. | Stock | 2.77% |
| 17 |  | Supernus Pharmaceuticals, Inc | Stock | 2.64% |
| 18 |  | Dyne Therapeutics, Inc. | Stock | 2.43% |
| 19 |  | Axogen, Inc. | Stock | 2.34% |
| 20 | C CO:HLUN.B | H Lundbeck A/S | Stock | 1.97% |
| 21 | H HLUNB.CO | H. LUNDBECK CLASS B | Stock | 1.86% |
| 22 | K KRX:326030 | SK Biopharmaceuticals Co., Ltd. | Stock | 1.75% |
| 23 | K KO:326030 | Sk Biopharmaceuticals Co Ltd | Stock | 1.73% |
| 24 |  | Sarepta Therapeutics, Inc. | Stock | 1.67% |
| 25 |  | Biohaven Ltd. | Stock | 1.63% |
| 26 |  | Taysha Gene Therapies, Inc. | Stock | 1.39% |
| 27 |  | Capricor Therapeutics, Inc. | Stock | 1.35% |
| 28 |  | Integra LifeSciences Holdings Corporation | Stock | 1.24% |
| 29 | S ST:BIOA.B | BioArctic AB (publ) | Stock | 1.18% |
| 30 |  | Rapport Therapeutics, Inc. Common Stock | Stock | 1.09% |
| 31 | A ASX:NEU | Neuren Pharmaceuticals Ltd | Stock | 1.08% |
| 32 | S SWX:IDIA | Idorsia Ltd | Stock | 1.04% |
| 33 | S ST:DYVOX | Dynavox Group | Stock | 0.77% |
| 34 | E EPA:MEDCL | Medincell SA | Stock | 0.71% |
| 35 |  | ANRO | Stock | 0.65% |
| 36 |  | Bright Minds Biosciences Inc | Stock | 0.64% |
| 37 |  | Annexon Inc | Stock | 0.64% |
| 38 |  | LB Pharmaceuticals Inc Common Stock | Stock | 0.57% |
| 39 |  | Brainsway Ltd | Stock | 0.53% |
| 40 |  | CBLL | Stock | 0.47% |
| 41 |  | Solid Biosciences Inc | Stock | 0.46% |
| 42 | T TSE:4592 | Sanbio Company Limited | Stock | 0.45% |
| 43 | T TSE:4588 | Oncolys Biopharma Inc | Stock | 0.45% |
| 44 |  | Neuropace Inc | Stock | 0.43% |
| 45 |  | Relmada Therapeutics, Inc | Stock | 0.42% |
| 46 |  | MapLight Therapeutics, Inc. Common Stock | Stock | 0.40% |
| 47 | H HKG:2172 | MicroPort NeuroTech Ltd | Stock | 0.39% |
| 48 |  | Benitec Biopharma Inc | Stock | 0.38% |
| 49 |  | Prothena Corporation plc | Stock | 0.38% |
| 50 | H HKG:2190 | Zylox-Tonbridge Med Tech Co | Stock | 0.38% |
Frequently Asked Questions About iShares Neuroscience and Healthcare ETF Holdings
What are the top holdings in IBRN?
iShares Neuroscience and Healthcare ETF (IBRN) holds 84 securities. View the complete list of top holdings sorted by portfolio weight, showing each security's ticker symbol, company name, asset type, and allocation percentage.
How concentrated is IBRN's portfolio?
Portfolio concentration is measured by the weight of top holdings. A concentrated portfolio has fewer large positions with higher individual weights, while a diversified portfolio distributes holdings more evenly. Review IBRN's holdings table to analyze concentration risk.
What is IBRN's sector allocation?
The Sector Allocation chart shows how IBRN distributes investments across different industries like Technology, Healthcare, Financials, and more. This sector exposure helps understand the fund's industry diversification strategy.
What countries does IBRN invest in?
IBRN's geographic exposure is shown in the Countries tab under Portfolio Allocations. This reveals the fund's international diversification and exposure to different regions and global markets.
How diversified is IBRN ETF?
IBRN's diversification can be assessed by reviewing its 84 holdings, sector allocation, and geographic exposure. A well-diversified ETF spreads investments across multiple securities, sectors, and regions to reduce concentration risk.